Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA).

Lucy GaoArielle MedfordLaura SpringYael BarBonnie HuRachel JimenezSteven J IsakoffAditya BardiaJeffrey M Peppercorn

Published in: Breast cancer research and treatment (2024)

This review suggests that the emerging promise of ctDNA may help resolve a crticical dilemma at the heart of breast cancer care, and improve prognostication, treatment selection, and outcomes for patients with breast cancer.

Keyphrases

circulating tumor
circulating tumor cells
cell free
big data
heart failure
atrial fibrillation
machine learning
metabolic syndrome
type diabetes
adipose tissue
skeletal muscle
replacement therapy